Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEACH: Tirzepatide in Obese Adults With Congenital Heart Disease
NCT07354880Phase 4Not yet recruiting
- Sponsor
- University Medical Centre Ljubljana
- Start
- Jan 2026
- Primary completion
- Jun 2027
- Modality
- Peptides, Recombinant Proteins and Enzymes
01
Overview
A Phase 4 trial of tirzepatide in obesity, sponsored by University Medical Centre Ljubljana. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07354880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07354880.